Overview
MICROPORT NEURO (2172)
MicroPort NeuroScientific Corporation provides neuro-interventional medical devices. The company provides NUMEN Silk, a electronically detachable coil; Numen Li...
- Open
- 8.055
- High
- 8.055
- Low
- 8.055
- Prev. Close
- 8.055
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- 0.00%
- 52wk High
- 14.440
- Volume Ratio
- 0.00
- Turnover Ratio
- --
- 52wk Low
- 8.005
- HK Mkt Cap
- 4.58B
- Market CapHKD
- 4.58B
- P/ETTM
- 22.42
- P/EDynamic
- 22.42
- P/EStatic
- --
- EPSTTM
- 0.359
- EPSDynamic
- 0.359
- EPSStatic
- --
- BVPS
- 3.50
- P/B
- 2.30
- HK Shares
- 568.54M
- Dividend YieldTTM
- 1.12%
- DividendTTM
- 0.090
- Shares
- 568.54M
- Min lot size
- 1,000
- Currency
- HKD
MICROPORT NEURO Analyst Rating
View moreForecast & Rating
Apr 6, 2026- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 1
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
Daily Events
- Jul, 3
MicroPort NeuroScientific opened higher but reversed lower throughout the session, rallying to an intraday high of HKD 11.00 before falling steadily to close at HKD 10.46, down 4.9% with turnover of approximately HKD 32.3 million. The company's recent share buybacks (e.g., at HKD 10.61-10.82 and HKD 10.98) and FDA clearance of the NUMEN Helia Coil were overshadowed by persistent selling pressure in the afternoon, with the stock touching its session low of HKD 10.46 at the close. Q4 2025 net profit fell 13.49% YoY to HKD 50.9 million despite a 20.5% revenue increase to HKD 226.6 million. The stock remains 36.37% below its 52-week high of HKD 16.44 and is down 7.43% YTD, though it trades above both its 20-day (HKD 10.06) and 60-day (HKD 10.09) moving averages. PE and PB stand at 29.11x and 2.99x, respectively. Bank of America Securities recently cut its target price to HKD 13.9 while maintaining a Buy rating.
News
Global Report · Hong Kong Hospital Stocks Have a New Script: Buybacks and Exits
Global Report · A Surgical Robot Lands in Singapore. Four Companies Still Can't Trade.
Global Report · Capital Recycling Mode: REITs Shed Assets as MedTech Bets on Regulatory Wins
Global Report · A Device Approval, a Frozen Stock: MicroPort NeuroTech's Long Halt
Global Report · Auto ETFs and Debt Deals: Hong Kong's Quiet Small-Cap Shift
Global Report · A Reinsurance Shake-Up and a Brain-Implant Trade: Hong Kong's Straggler Stocks
